Navigation Links
Contraceptive Patch Carries Risk of Blood clots

The U.S. Food and Drug Administration on Wednesday reported having updated the warning label on the Ortho Evra birth-control patch, cautioning users about the higher risk of blood clots from it.//

The drug manufacturer Johnson and Johnson’s commissioned study revealed that drug users faced two times the risk of clots in the legs and lungs compared to women taking traditional birth-control pills.

Another study commissioned by Johnson and Johnson, however, found no difference in risk between the patch and the pill. The FDA said, "Even though the results of the two studies are conflicting, the results of the second epidemiology study support FDA's concerns regarding the potential for Ortho Evra use to increase the risk of blood clots in some women."

Dr. Daniel Shames, the acting deputy director of FDA's Office of Drug Evaluation in the Center for Drug Evaluation and Research, said, "Blood clots occurring in the legs or lungs are serious and rare events that are a potential risk for all hormonal contraceptive therapies."

Shames said that risk factors for blood clots associated with contraceptives include smoking, inactivity, obesity, surgery and high doses.

The FDA has also required Johnson and Johnson to conduct a longer follow-up study of women using the patch to check for developments of heart attack, blood clots and stroke. Currently, the FDA believes the patch is safe for most women. Shames said, "Ortho Evra risk profile is acceptable for a highly effective contraceptive."

However the FDA’s concerns about the potential risk of blood clots in some women could not be ruled.

Earlier information that had been reported by Johnson and Johnson in a Feb. 16, 2006, press release was also included in the label change. This information was partly based, on an interim report from one of the two studies. The FDA said that the label change announced on Wednesday is based on the latest results from the two studies.
'"/>




Page: 1 2

Related medicine news :

1. Contraceptives via Internet
2. FDA Approves Contraceptive Ring
3. Contraceptives decreases Libido
4. Contraceptives have dual effects
5. Drugs For Anthrax May Interfere With Oral Contraceptives
6. Contraceptive pill to reduce PMS
7. Smoking and Oral Contraceptives:
8. Contraceptive pills may lead to deformities in babies
9. Low-Dose Oral Contraceptives May Increase Risk For Heart Attack Or Stroke
10. Prevent Multiple Sclerosis From Oral Contraceptives
11. Usage Of Oral Contraceptives Need Not Be Feared By SLE Patients
Post Your Comments:
(Date:10/7/2008)...g out of bed sooner helped quality of life after d...7 (HealthDay News) -- The best medicine for intens...ut of bed and moving as soon as they,re able, a ne...ent data, Johns Hopkins University School of Medic...deep sedation and bed rest may cause unnecessary a...
(Date:10/7/2008)...ikely to feel distress, more likely to enjoy bette...AY, Oct. 7 (HealthDay News) -- End-of-life discuss... do not result in more distress for patients. In f...entions and enhanced quality of life in a patient,...the past two decades, the debate has been around w...
(Date:10/7/2008)...DONA, Ariz., Oct. 7 /PRNewswire/ -- Join Mii amo, ...r-day celebration in Sedona,s red rock,country hon...es include a,series of traditional Native American... Director R.J. Joseph and special guest, Elder Geo... Blackfoot Elder from the Blood Reserve,in Standof...
(Date:10/7/2008)...U CLAIRE, Wis., Oct. 7 /PRNewswire/ -- Van Wert Co...st facility to go live with LOGICARE(R),Corp.,s ne...) EDIS., Van Wert County Hospital joins Conway Re...ern New Hampshire Medical Center, Nashua, New Hamp...mergency Departments., Van Wert County Hospital b...
Breaking Medicine News(10 mins):Health News:Early Mobility Best for ICU Patients 2Health News:Patients Benefit From End-of-Life Discussions With a Doctor 2Health News:Patients Benefit From End-of-Life Discussions With a Doctor 3Health News:Mii amo Honors Winter Solstice With Traditional Native American Celebration December 18-21 2Health News:Latest LOGICARE(R) EDIS User Sees 'Tremendous Results' 2
...or just apathy- What do you say , to yet another ...after being given a medicine that was not meant f...asgow's Stobhill Hospital in the emergency ward, a...4. NHS, has confirmed that Miss Maguire, by a qui...
...oughing up ?4,500 for Jiffy breast implant operati...r such breast implant operations//, and is getting...t Jessica Kirkham was one of the first to be on th...sired chest-lift, funded partly by her mom and a s...
...ing health care cost and increase the availability...W. Bush has urged the citizens to invest // in hea...ax dollars. At the time of need, the funds can be .... High deductible health insurance policies and l...
...er were drowned in the River Ganga after a village...hat the two were witches//. Police were able to re...a district in north region of the state. They had...orted that Anita, the wife of a daily wage laborer...
Other Medicine News:Health News:President Bush Urges Citizens to Invest In Health Savings Account (HSAs) 2
(Date:10/6/2008)... - Data Presented at ACG Annual Scient...ire/ -- Ironwood Pharmaceuticals,(formerly Microbi...r of,preclinical studies delineating the role that...leviating intestinal pain. These studies,demonstra...ical model of,intestinal hyperalgesia and desensit...
(Date:10/6/2008)... Experts Discuss Promising Research at The Amer... Annual Meeting, WASHINGTON, Oct. 6 /PRNewswir...n children and seniors was presented at The Americ...symposium, "Practical Applications of,Probiotics i...ields of,pediatrics, aging, and nutrition discusse...
(Date:10/6/2008)... PLYMOUTH MEETING, Pa., Oct. 6 /PRNewswire-Fi...oday reported data from its second Phase 1,clinica...d drug candidate,for the treatment of type 2 diabe...PTP1B, a validated molecular target that controls ...ys to normalize glucose and decrease,appetite. In ...
(Date:10/6/2008)... - Conference Call Scheduled for 9:0...tCall/ -- Dendreon Corporation (Nasdaq:,DNDN) anno...rim analysis of,the Phase 3, randomized, double-bl...Prostate AdenoCarcinoma Treatment, also known as D...y and efficacy of the,investigational active cellu...
Breaking Medicine Technology:Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 2'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 4Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Louisiana Tech researchers investigate tracking sensors to assist Air Force 324 1Louisiana Tech researchers investigate tracking sensors to assist Air Force 324 2Louisiana Tech researchers investigate tracking sensors to assist Air Force 324 3Small Incisions Make Heart Valve Surgery Safer 918 1Small Incisions Make Heart Valve Surgery Safer 918 2Small Incisions Make Heart Valve Surgery Safer 918 3 26 239 3BDrug free treatments offer hope for older people in pain 915 1Medifast Announces Winners of Mother Daughter Challenge 912 1Medifast Announces Winners of Mother Daughter Challenge 912 2Medifast Announces Winners of Mother Daughter Challenge 912 3
...ested in Patients Reduces,Severity of Adult Leukae... the Danish,biopharmaceutical company, announced t...t of Bcl-2, has shown early evidence of,efficacy i...Lymphocytic Leukaemia (CLL). The results of the st...ting of the American Society of,Clinical Oncology,...
...7 - Inovio Biomedical,Corporation (AMEX:INO), focu... and infectious diseases and a novel alternative t...day the company,delivered multiple presentations o...ions relating to its electroporation-mediated DNA,...the American,Society of Gene Therapy (ASGT). Inovi...
Other Medicine Technology:Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 2Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 3Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 4Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 5Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 6Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 7Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 8Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 9Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with,Electroporation DNA Delivery Technology and New Devices at Gene,Therapy Meeting 2Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with,Electroporation DNA Delivery Technology and New Devices at Gene,Therapy Meeting 3Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with,Electroporation DNA Delivery Technology and New Devices at Gene,Therapy Meeting 4Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with,Electroporation DNA Delivery Technology and New Devices at Gene,Therapy Meeting 5
...ydroepiandrosterone sulfate (DHEA-S) is the sulfat...and by enzymatic conversion of DHEA in adrenal and...d secreted by the adrenal cortex, and is a precurs...A possesses relatively weak androgenic activity, w...
EL-RF-IgM is high sensitivity quantitative rheumatoid factor IgM.
The Diamedix immunosimplicity® Is- Rheumatoid Factor Test Kit is an EIA procedure intended for the quantitation of IgM antibodies to IgG antigen. The results are reported in IU/mL, traceable to t
The SYNCHRON CX4 Delta Specialty / Drug Clinical System is a random access analyzer that can consolidate Drugs of Abuse, TDM's and other specialty testing, such as thyroid, HbA1c and lipids in one co
Medicine Products: